## Opioid Selection in Hepatic Failure **Key Point:** Remifentanil is the only opioid with ester hydrolysis by non-specific plasma esterases, independent of hepatic function, making it safe in severe cirrhosis without accumulation. ### Opioid Metabolism in Liver Disease | Opioid | Metabolism | Hepatic Dependency | Active Metabolites | Safe in Cirrhosis | |--------|-----------|-------------------|-------------------|-------------------| | Remifentanil | Plasma ester hydrolysis | None | None | ✓ Yes | | Morphine | Hepatic glucuronidation | High | Morphine-6-glucuronide (active) | No | | Codeine | Hepatic O-demethylation | High | Morphine (active) | No | | Tramadol | Hepatic oxidation | High | O-desmethyltramadol (active) | No | **High-Yield:** Remifentanil's metabolism is unique: 1. Hydrolyzed by **non-specific plasma esterases** (present in blood, not liver) 2. Metabolism continues even in hepatic failure 3. No active metabolite accumulation 4. Rapid offset (half-life ~10–20 min) independent of organ function ### Why Other Opioids Fail **Clinical Pearl:** In Child-Pugh C cirrhosis, hepatic opioid metabolism is severely impaired: - **Morphine** forms active metabolite (M6G) that accumulates → respiratory depression, encephalopathy - **Codeine** is a prodrug requiring hepatic demethylation to morphine; conversion is blocked → poor analgesia or accumulation - **Tramadol** undergoes hepatic oxidation; active metabolite accumulates → seizures, serotonin syndrome **Mnemonic:** **REMIFENTANIL = Rapid Ester Metabolism, Independent of liver** — the only opioid safe in hepatic failure. ### Mechanism of Safety Remifentanil's ester linkage is cleaved by ubiquitous plasma esterases present in erythrocytes and other tissues. This extrahepatic metabolism ensures predictable pharmacokinetics regardless of hepatic synthetic function, making it ideal for this patient.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.